CenTrial Logo

Enhancing Diabetic Foot Ulcer Healing with Dermaheal


Clinical trial finds that Dermaheal ointment provides faster healing and smaller diabetic foot ulcers

Diabetic foot ulcers (DFUs) pose a significant threat to the health and mobility of individuals with diabetes, often leading to complications like infections and amputations. Traditional treatments can be costly and may come with adverse effects. However, a clinical trial has shed light on a promising natural solution: Dermaheal ointment. This groundbreaking research could revolutionize DFU treatment.

Clinical Trial

In a clinical trial, researchers investigated the effects of Dermaheal ointment on 50 patients with diabetic foot ulcers. The patients were randomly assigned to either the Dermaheal or the placebo group, receiving standard treatment with either Dermaheal or a placebo ointment. The ulcers were dressed daily for four weeks, and various parameters were monitored to assess the treatment's effectiveness.


The trial revealed significant improvements in ulcer healing over the four weeks in both groups. However, the Dermaheal group showed more remarkable progress than the placebo group. At the end of the trial, 56% of ulcers in the Dermaheal group had completely healed, whereas only 12% had healed in the placebo group. Additionally, the Dermaheal group exhibited a more substantial reduction in ulcer size compared to the placebo group, indicating the ointment's effectiveness in promoting healing.


These findings hold promising implications for the treatment of DFUs. Dermaheal, as a topical treatment, has shown potential in improving healing and reducing the size of diabetic foot ulcers. By harnessing the power of natural products, patients may have access to a safer and more cost-effective alternative to traditional therapies.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me

While the short-term effects of Dermaheal are encouraging, further research is needed to validate its long-term efficacy. Continued investigation into the ointment's benefits and potential side effects will provide valuable insights into its role in diabetic foot ulcer management.


The results of this clinical trial highlight the potential of Dermaheal ointment as a game-changer in the treatment of diabetic foot ulcers. With its ability to promote healing and reduce ulcer size, Dermaheal offers new alternatives for individuals grappling with this debilitating condition. As researchers delve deeper into its effectiveness, Dermaheal could emerge as a cornerstone of diabetic foot ulcer therapy, improving outcomes and enhancing the quality of life for patients worldwide.


Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Whether you're healthy or have a medical condition you can participate in a clinical trial.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.